• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I SYPHILIS TP REAGENT KIT; ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM Back to Search Results
Catalog Number 07P60-77
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/03/2022
Event Type  malfunction  
Event Description
The customer stated that repeat reactive alinity i syphilis tp results of 1.27 and 1.24 s/co were generated for a 2 year old male patient (sid (b)(6)).The customer retested the sample on a different alinity i processing module and the results were nonreactive at 0.48 and 0.50 s/co (reagent lot 37093be01).Syphilis testing using alternate methods (rpr and trust) were negative.No impact to patient management was reported.Additional discrepant patient results were reported for three patients on (b)(6) 2022.Sid (b)(6): 1.37 s/co (reactive) and 0.57 s/co (nonreactive), male, 1 year-old, department of pediatric surgery.Sid (b)(6): 1.97 s/co (reactive) and 0.82 s/co (nonreactive), male, 1 year-old, department of pediatric surgery.Sid (b)(6): 2.21 s/co (reactive) and 0.77 s/co (nonreactive), female, 1 year-old, department of respiratory medicine.No additional testing was performed for these three patients, but from the clinical perspective, the nonreactive results are preferred.However, the customer is questioning the nonreactive results generated with reagent lot 37093be01.No impact to patient management was reported.
 
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event Description
Clarification of the customer issue: since the clinical side preferred the nonreactive results for the patients specified, alinity i syphilis tp reagent lot 37093be01 is not considered a suspect medical device for false nonreactive results.
 
Manufacturer Narrative
Since the clinical side preferred the nonreactive results for the patients specified, alinity i syphilis tp reagent lot 37093be01 is not considered a suspect medical device for false nonreactive results.H3 other text: device not considered suspect upon further review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I SYPHILIS TP REAGENT KIT
Type of Device
ENZYME LINKED IMMUNOABSORPTION ASSAY, TREPONEMA PALLIDUM
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
siobhan wright
lisnamuck
post market surveillance
longford N39 E-932
EI   N39 E932
433331157
MDR Report Key16075201
MDR Text Key308501668
Report Number3002809144-2022-00460
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K153730
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07P60-77
Device Lot Number37093BE01
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/03/2022
Initial Date FDA Received12/29/2022
Supplement Dates Manufacturer Received02/01/2023
Supplement Dates FDA Received02/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, (B)(6); ALNTY I PROCESSING MODU, 03R65-01, (B)(6)
Patient Age2 YR
Patient SexMale
-
-